Sumitomo Pharma's Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive ...

Discover how cold weather can trigger prostate problems in men over 60, including frequent urination, hormonal changes, and ...

Gemtesa (vibegron) has been approved by the U.S. Food and Drug Administration for men with overactive bladder (OAB) s ...

An overactive bladder may be temporary or become a chronic condition. How long the symptoms last may depend on factors like the underlying cause and treatment adherence. Some conditions may cause ...

The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.

Cold weather can trigger frequent urination, hormonal changes and diuresis, especially in men over the age of 60.

Urination problems affect millions of men worldwide, often developing so gradually that many dismiss early warning signs.

Interestingly, the study also found that men with lower vitamin D levels who took supplements saw a reduction in overactive ...

We have several treatment options for overactive bladder. The medications we use can have harsh side effects, so we prefer to start with a more natural and gentle approach. The first thing we ask ...

The term "voiding dysfunction" has been used to refer to urinary incontinence, urinary retention and symptoms of frequency and urgency. Overactive bladder is a specific type of voiding dysfunction ...

The Food and Drug Administration (FDA) has approved Gemtesa ® (vibegron) for the treatment of overactive bladder (OAB ... milestone for the men with unresolved symptoms of OAB while being ...